Abstract Food allergy affects approximately 2–4% of children and adults. This guideline
provides recommendations for managing food allergy from the Global Allergy and Asthma …

This rapid review summarizes the most up to date evidence about the risk factors for severe
food‐induced allergic reactions. We searched three bibliographic databases for studies …

Background No approved treatment for peanut allergy exists for children younger than 4
years of age, and the efficacy and safety of epicutaneous immunotherapy with a peanut …

Pneumologists, Sleep and Respiratory Physicians (BdP)(Sebastian Böing), Professional
Association of German Dermatologists (BVDD)(Klaus Strömer) were taking part in the …

Background A growing number of studies have shown encouraging results with omalizumab
(OMA) as monotherapy and as an adjunct to oral immunotherapy (OMA+ OIT) in patients …

This practice parameter update focuses on 7 areas in which there are new evidence and
new recommendations. Diagnostic criteria for anaphylaxis have been revised, and patterns …

Background Food is one of the most common elicitors of anaphylaxis, with an increasing
incidence over recent years. Objectives To characterize elicitor-specific phenotypes and …

Background Peanut allergy is a type‐I hypersensitivity immune reaction mediated by the
binding of peanut allergens to IgE‐FcεRI complexes on mast cells and basophils and by …

The 21st century has seen the propulsion of research in the field of food allergy, which has
driven real changes in the clinical approach. Allergen immunotherapy has been …

Food allergy is a chronic disease that affects individuals of all ages and is a significant
public health problem globally. This narrative overview examines clinical management …